Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trialJean‐Claude Tardif, Guy Boivin, José López‐Sendón et al.|The Lancet Respiratory Medicine|2021Cited by 271
Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular DiseasePhilip C. Robinson, Mark Nidorf, Robert Terkeltaub et al.|The American Journal of Medicine|2021Cited by 122